Background: Retinoids can suppress carcinogenesis in high-risk nonneoplasti
c bronchial lesions and can reduce the risk of second primary non-small-cel
l lung cancer (NSCLC), The effects of retinoids are mediated by nuclear rec
eptors, i.e., the retinoic acid receptors (RAR alpha, RAR beta, and RAR gam
ma) and the retinoid X receptors (RXR alpha, RXR beta, and RXR gamma), We i
nvestigated whether abnormalities in the in vivo expression of retinoid rec
eptors are observed in NSCLC, Methods: Expression of retinoid receptors in
paired specimens of normal and cancerous tissues from the lungs of 76 patie
nts with NSCLC was studied by use of anti-retinoid receptor antibodies (exc
ept those against RXR gamma) and immunohistochemistry. RAR messenger RNAs w
ere analyzed by use of irt situ hybridization and by reverse transcription-
polymerase chain reaction (RT-PCR), Samples were also studied for loss of h
eterozygosity (LOH) at chromosome 3p24, All P values are two-sided. Results
: All studied receptors were expressed in normal lung cells and in high- ri
sk non-neoplastic lesions, In tumor cells, overexpression of RXR alpha and
RAR alpha was frequently observed. In contrast, RXR beta expression decreas
ed in 18% of the tumor specimens. Furthermore, there was a marked decrease
in the expression of RAR beta in 63% of the tumors (P<.0001). Decreased exp
ression of RAR gamma was observed by RT-PCR in 41% of the tumors (P<.0001),
LOH at 3p24 was observed in 41% of the tumor specimens from informative pa
tients and in 20% of the non-neoplastic lesions. Conclusions: Expression of
RAR alpha and RXR alpha is either normal or elevated in NSCLC, In contrast
, a large percentage of tumors show a marked decrease in the expression of
RAR beta, RAR gamma, and RXR beta as well as a high frequency of LOH at 3p2
4, which was also observed in non-neoplastic lesions. These data suggest th
at altered retinoid receptor expression may play a role in lung carcinogene
sis.